Clinical Trial Update: Controlled Arterial Protection to Ultimately Remove Embolic Material [NA]

View source ↗

Summary

EmStop Inc reported completed results from a clinical trial evaluating controlled arterial protection to remove embolic material in patients with aortic valve s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Snippet

Sponsor: EmStop Inc | Conditions: Aortic Valve Stenosis | NA | Status: COMPLETED | Results posted: 2025-04-29